The diagnostic utility of maspin in the distinction between malignant mesothelioma and pulmonary adenocarcinoma

Journal of International Medical Research

Volumn 38, Issue 3, 2010, Pages 1070-1076

  Akyildi, E U ^a   Oz, B ^b   Sehitoglu, I ^a   Demir, H ^b  

^a ULUDAG UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Expression; Immunohistochemistry; Malignant mesothelioma; Maspin; Pulmonary adenocarcinoma

Indexed keywords

MASPIN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SERPIN-B5; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPITHELIOID CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MALE; MALIGNANT MESOTHELIOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; ADENOCARCINOMA; CHEMISTRY; ENZYME IMMUNOASSAY; EVALUATION STUDY; LUNG NEOPLASMS; MESOTHELIOMA; MIDDLE AGED; NEOPLASMS, MESOTHELIAL; PREDICTIVE VALUE; SECONDARY;

ADENOCARCINOMA; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASMS, MESOTHELIAL; PREDICTIVE VALUE OF TESTS; SERINE PROTEINASE INHIBITORS; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954792694     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800334     Document Type: Article

References (22)

1. Ordóñez NG: Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma. Review and update. Am J Clin Pathol 1999; 112: 75-89.
2. Ordóñez NG: Immunohistochemical diagnosis of epithelioid mesothelioma: an update. Arch Pathol Lab Med 2005; 129: 1407-1414.
3. Ordóñez NG: The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003; 27: 1031-1051.
4. Comin CE, Novelli L, Boddi V, et al: Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial meso-thelioma from peripheral pulmonary adeno - carcinoma. Hum Pathol 2001; 32: 529-536.
5. Abutaily AS, Addis BJ, Roche WR: Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J Clin Pathol 2002; 55: 662-668.
6. Yaziji H, Battifora H, Barry TS, et al: Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immuno -histochemical panel with maximal sensitivit and specificity. Mod Pathol 2006; 19: 514-523.
7. Zou Z, Anisowicz A, Hendrix MJ, et al: Maspin, serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994; 263: 526-529.
8. Sheng S, Pemberton PA, Sager R: Production, purification, and characterization of recombinant maspin proteins. J Biol Chem 1994; 269: 30988-30993.
9. Sheng S, Carey J, Seftor EA, et al: Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 1996; 93: 11669-11674.
10. Sheng S, Truong B, Fredrickson D, et al: Tissuetype plasminogen activator is a target of the tumor suppressor gene maspin. Proc Natl Acad Sci USA 1998; 95: 499-504.
11. Pemberton PA, Tipton AR, Pavloff N, et al: Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface. J Histochem Cytochem 1997; 45: 1697-1706.
12. Ngamkitidechakul C, Burke JM, O'Brien WJ, et al: Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix. Invest Ophthalmol Vis Sci 2001; 42: 313-3141.
13. Reis-Filho JS, Torio B, Albergaria A, et al: Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Arch 2002; 441: 551-558.
14. Sood AK, Fletcher MS, Gruman LM, et al: The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002; 8: 2924-2932.
15. Ikegami Y, Kawai N, Tozawa K, et al: Malignant mesothelioma of the tunica vaginalis testis related to recent asbestos. Int J Urol 2008; 15: 560-561.
16. Schneider SS, Schick C, Fish KE, et al: A serine proteinase inhibitor locus at 18q21.3 contains atandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 1995; 92: 3147-3151.
17. Zou Z, Zhang W, Young D, et al: Maspin expression profile in human prostate cancer (CaP) and in vitro induction of maspin expression by androgen ablation. Clin Cancer Res 2002; 8: 1172-1177.
18. Nakashima M, Ohike N, Nagasaki K, et al: Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma. J Cancer Res Clin Oncol 2004; 130: 475-479.
19. Nakagawa M, Katakura H, Adachi M, et al: Maspin expression and its clinical significance in non-small cell lung cancer. Ann Surg Oncol 2006; 13: 1517-1523.
20. Katakura H, Takenaka K, Nakagawa M, et al: Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Maspin in NSCLC. Lung Cancer 2006; 51: 323-328.
21. Hirai K, Koizumi K, Haraguchi S, et al: Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Ann Thorac Surg 2005; 79: 248-253.
22. Lonardo F, Li X, Siddiq F, et al: Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer 2006; 51: 31-39